Articles by Rita Peters - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Rita Peters
12
Next »

Pathway to Publication

Wanted: Article contributions on drug and process development topics.
May 2, 2013
By: Rita Peters

Wanted: Article contributions on drug and process development topics.

FDA Will Not Approve Generics to Original OxyContin

Apr 17, 2013
By: Rita Peters

The FDA approved updated labeling for Purdue Pharma L.P.?s reformulated OxyContin tablets, but also determined that it will not approve generic versions of the original OxyContin.

More than 900 Biologics in Development

Mar 11, 2013
By: Rita Peters

America's biopharmaceutical companies are using biological processes to develop 907 medicines and vaccines targeting more than 100 diseases, according to a new report.

European Patent Filings Up, But Pharma Stays Flat

Mar 7, 2013
By: Rita Peters

While the number of patent filings at the European Patent Office in 2012 increased by 5.2% over 2011, pharmaceutical-based patents remained flat, and biotechnology patents dropped slightly.

Russian Lab Achieves ISO Accreditation

Mar 5, 2013
By: Rita Peters

The Rostov-on-Don Medicines Quality Control Laboratory is the first official medicines control laboratory in Russia to have achieved internationally recognized ISO accreditation.

Catching Up

QbD paradigm advances process understanding in development and manufacturing.
Mar 2, 2013
By: Rita Peters

QbD paradigm advances process understanding in development and manufacturing.

Sequestration Threatens Life Sciences, Drug Development

Mar 1, 2013
By: Rita Peters

Mandatory cuts threaten to slow research and patient access to new therapies, Burrill & Company says.

Capsugel Acquires Encap Drug Delivery

Mar 1, 2013
By: Rita Peters

Capsugel’s acquisition of Encap Drug Delivery expands its lipid expertise and adds an FDA-inspected commercial manufacturing facility.

European Commission Authorizes First Therapy for Alcohol Dependence

Feb 28, 2013
By: Rita Peters

The European Commission has granted H. Lundbeck A/S marketing authorization for Selincro (nalmefene) for the reduction of alcohol consumption in adult patients with alcohol dependence.

12
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
22%
To all process for new products only
12%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here